Andrew R. Swartz
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0003-4812-2966Biochemistry, Genetics and Molecular BiologyMedicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 1 paper. Top paper: “Functionalized nanoparticle crosslinking for enhanced affinity precipitation of monoclonal antibodies”.
2 citations
Andrew R. Swartz